South Korea Brachytherapy Market Size, Share, and COVID-19 Impact Analysis, By Product (Seeds and Electronic Brachytherapy), By Application (Prostate Cancer and Breast Cancer), and South Korea Brachytherapy Market Industry Trend, Forecasts to 2035
Industry: HealthcareSouth Korea Brachytherapy Market Insights Forecasts to 2035
- The South Korea Brachytherapy Market Size Was Estimated at USD 24.68 Million in 2024
- The Market Size is Expected to Grow at a CAGR of around 8.71% from 2025 to 2035
- The South Korea Brachytherapy Market Size is Expected to Reach USD 61.87 Million by 2035
Get more details on this report -
According to a research report published by Spherical Insights & Consulting, the South Korea Brachytherapy Market is anticipated to reach USD 61.87 million by 2035, growing at a CAGR of 8.71% from 2025 to 2035. The market is anticipated to develop over the projected period due to a number of factors, including rising cancer prevalence, technological advancements, and a notable increase in the use of brachytherapy. One kind of radiation therapy used to treat cancer is called brachytherapy. Catheters are used to introduce the radioactive materials into the body.
Market Overview
The brachytherapy market involves the use of internal radiation therapy where radioactive sources are placed close to or inside tumors to treat cancers such as prostate and breast cancer. The precise radiation delivery, minimal damage to surrounding healthy tissues, reduced treatment time, and fewer side effects compared to external radiation therapy. The market arises from increasing cancer prevalence, advancements in technology, and growing patient awareness. Governments, including in South Korea, support the market through healthcare funding, cancer screening programs, and initiatives promoting advanced cancer treatments. These efforts aim to improve accessibility, encourage early diagnosis, and foster innovation in brachytherapy, driving market growth and enhancing patient outcomes.
Report Coverage
This research report categorizes the market for South Korea brachytherapy market based on various segments and regions, forecasts revenue growth, and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the South Korea brachytherapy market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment South Korea brachytherapy market.
South Korea Brachytherapy Market Report Coverage
Report Coverage | Details |
---|---|
Base Year: | 2024 |
Market Size in 2024: | USD 24.68 Million |
Forecast Period: | 2024-2035 |
Forecast Period CAGR 2024-2035 : | 8.71% |
2035 Value Projection: | USD 61.87 Million |
Historical Data for: | 2020-2023 |
No. of Pages: | 180 |
Tables, Charts & Figures: | 130 |
Segments covered: | By Product, By Application and COVID-19 Impact Analysis. |
Companies covered:: | Dongbang Medical, Noninvasive Medical System, BTG International Medicine (Korea), GE Healthcare Korea (International Radiology & Oncology), Elekta Korea, Oncology Imaging Systems Korea Company, INFINITY Healthcare, RF Medical Co. Ltd, GC Pharma (Green Cross Corporation), Taewoong Medical Co. Ltd, and Others. |
Pitfalls & Challenges: | Covid-19 Empact, Challenges, Growth, Analysis |
Get more details on this report -
Driving Factors
The increasing prevalence of cancers such as prostate, breast, and cervical cancers is a significant factor, as brachytherapy offers targeted treatment with minimal damage to surrounding healthy tissues. Technological advancements, including image-guided therapy and high-dose-rate systems, have enhanced treatment precision and patient outcomes. Additionally, the preference for minimally invasive procedures, shorter hospital stays, and favorable reimbursement policies contribute to the market's expansion.
Restraining Factors
The high treatment costs and limited availability of skilled professionals which can hinder widespread adoption. Complex treatment planning and the need for specialized equipment also pose challenges, particularly in low-resource settings. Additionally, the preference for alternative cancer therapies, such as external beam radiation or chemotherapy, reduces demand in some regions.
Market Segmentation
The South Korea brachytherapy market share is classified into product and application.
- The seeds segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.
The South Korea brachytherapy market is segmented by product into seeds and electronic brachytherapy. Among these, the seeds segment held a significant share in 2024 and is expected to grow at a substantial CAGR during the forecast period. It's proven effectiveness, established clinical use, and cost-efficiency in treating various cancers, especially prostate cancer. Seeds offer precise radiation delivery directly to tumors, minimizing damage to surrounding healthy tissue. Additionally, widespread physician familiarity and well-established regulatory approvals support its continued preference.
- The prostate cancer segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.
The South Korea brachytherapy market is segmented by application into prostate cancer and breast cancer. Among these, the prostate cancer segment dominated a share in 2024 and is expected to grow at a significant CAGR during the forecast period. The high prevalence of prostate cancer and the effectiveness of brachytherapy in its treatment. Brachytherapy offers targeted radiation with fewer side effects, shorter treatment times, and improved patient outcomes, making it a preferred option. Increasing awareness, early diagnosis, and advancements in brachytherapy techniques further drive demand.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the South Korea brachytherapy market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the companies' current news and developments, including product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
List of Key Companies
- Dongbang Medical
- Noninvasive Medical System
- BTG International Medicine (Korea)
- GE Healthcare Korea (International Radiology & Oncology)
- Elekta Korea
- Oncology Imaging Systems Korea Company
- INFINITY Healthcare
- RF Medical Co. Ltd
- GC Pharma (Green Cross Corporation)
- Taewoong Medical Co. Ltd
- Others
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Market Segment
This study forecasts revenue at South Korea, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the South Korea brachytherapy market based on the below-mentioned segments:
South Korea Brachytherapy Market, By Product
- Seeds
- Electronic Brachytherapy
South Korea Brachytherapy Market, By Application
- Prostate Cancer
- Breast Cancer
Need help to buy this report?